Regulatory overview of CBD under the 2018 Farm Bill and FDA authority

Regulatory overview of CBD under the 2018 Farm Bill and FDA authority The passage outlines publicly known regulatory changes and FDA statements about CBD. It contains no new allegations, financial flows, or links to powerful individuals beyond the mention of FDA Commissioner Scott Gottlieb, offering minimal investigative value. Key insights: 2018 Farm Bill declassifies industrial hemp and shifts regulatory authority from DEA to USDA.; FDA retains authority over CBD products intended for human consumption.; FDA Commissioner Scott Gottlieb issued statements reaffirming regulatory oversight and warning against unapproved health claims.